Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial-Reference-Cited by-同舟云学术

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial

Published:2013-12-02 Issue:9 Volume:73 Page:1626-1634
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Huizinga Tom W J,Fleischmann Roy M,Jasson Martine,Radin Allen R,van Adelsberg Janet,Fiore Stefano,Huang Xiaohong,Yancopoulos George D,Stahl Neil,Genovese Mark C

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference38 articles.

1. Evolution of treatment for rheumatoid arthritis;Upchurch;Rheumatology (Oxford),2012

2. Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis;Katchamart;Cochrane Database Syst Rev,2010

3. Enbrel (etanercept) prescribing information. http://pi.amgen.com/united_states/enbrel/derm/enbrel_pi.pdf. (accessed 23 Jul 2013).

4. HUMIRA (adalimumab) prescribing information. http://www.rxabbott.com/pdf/humira.pdf (accessed 23 Jul 2013).

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing;International Journal of Biological Macromolecules;2024-10

2. Emerging trends and therapeutic applications of monoclonal antibodies;Gene;2024-10

3. Comprehensive approaches to preclinical evaluation of monoclonal antibodies and their next-generation derivatives;Biochemical Pharmacology;2024-07

4. Pharmacogenetics of therapies in rheumatoid arthritis: An update;Best Practice & Research Clinical Rheumatology;2024-07

5. A Complete Sojourn of Monoclonal Antibodies: AI, Rare Diseases / Disorders and Immunotoxic Effects;Current Proteomics;2024-06